IP Library Granted Patent US 7,514,538
Granted Patent B2
US 7,514,538 · App. 12/031,612 · Granted Apr 7, 2009

Compositions and methods for the diagnosis and treatment of tumor

Assignee: Genentech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,514,538
App. No.
12/031,612
Granted
Apr 7, 2009
Kind
B2
Abstract

The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.

Claims (14)

1. An isolated antibody which binds specifically to the polypeptide of SEQ ID NO:3.

2. The antibody of claim 1 which is a monoclonal antibody.

3. The antibody of claim 1 which is an antibody fragment that binds specifically to the polypeptide of SEQ ID NO: 3.

4. The antibody of claim 1 which is a chimeric or a humanized antibody.

5. The antibody of claim 1 which is conjugated to a growth inhibitory agent.

6. The antibody of claim 1 which is conjugated to a cytotoxic agent.

7. The antibody of claim 6 , wherein the cytotoxic agent is selected from the group consisting of toxins, antibodies, radioactive isotopes and nucleolytic enzymes.

8. The antibody of claim 6 , wherein the cytotoxic agent is a toxin.

9. The antibody of claim 8 , wherein the toxin is selected from the group consisting of maytansinoid and calicheamicin.

10. The antibody of claim 8 , wherein the toxin is a maytansinoid.

11. The antibody of claim 1 which is produced in bacteria.

12. The antibody of claim 1 which is produced in CHO cells.

13. The antibody of claim 1 which induces death of a cell to which it binds.

14. The antibody of claim 1 which is detectably labeled.

Continuity (14)
Continuation 1091625000 · Aug 11, 2004
Continuation 1012516600 · Apr 17, 2002
Continuation In Part 0991858500 · Jul 30, 2001
Continuation In Part 0990455300 · Jul 13, 2001
Continuation In Part PCTUS010652000 · Feb 28, 2001
Continuation In Part 0966535000 · Sep 18, 2000
Continuation In Part PCTUS000441400 · Feb 22, 2000
Continuation In Part PCTUS000434100 · Feb 18, 2000
Continuation In Part PCTUS992109000 · Sep 15, 1999
Continuation In Part PCTUS990502800 · Mar 8, 1999
Continuation In Part PCTUS981933000 · Sep 16, 1998
Provisional Application 6007764900 · Mar 11, 1998
Provisional Application 6006354200 · Oct 28, 1997
Related Publication 20080200653A1 · Aug 21, 2008